Nuzenio

Sanreco Trial Outcomes

Sanreco Trial Outcomes news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 9 latest news signals 8 publisher sources 100/100 entity strength

Latest news

Silence posts mid-stage polycythemia vera win, preps for Phase III - FirstWord PharmaFirstWord Pharma · Mon, 10 Aug 2026 18:02:18 GMT Silence Therapeutics Says Blood Cancer Trial Delivers 'Best-Case Outcome' - BenzingaBenzinga · Mon, 10 Aug 2026 14:15:58 GMT Silence Therapeutics Announces Positive Phase 2 SANRECO Trial Outcomes for Divesiran in Polycythemia Vera - Kalkine MediaKalkine Media · Mon, 10 Aug 2026 14:00:27 GMT Silence Therapeutics Reports Second Quarter 2026 Financial and Business Results - BioSpaceBioSpace · Mon, 10 Aug 2026 12:48:16 GMT Silence Therapeutics Q2 EPS of $(0.09) beats $(0.15) estimate - scanx.tradescanx.trade · Mon, 10 Aug 2026 11:52:25 GMT Silence announces results from Phase 2 SANRECO trial met primary endpoint - TipRanksTipRanks · Mon, 10 Aug 2026 11:41:31 GMT Silence Therapeutics Announces Positive Topline Results from Phase 2 SANRECO Trial of Divesiran in Polycythemia Vera, Supporting its Potential Best-in-Class Profile - Business WireBusiness Wire · Mon, 10 Aug 2026 11:30:00 GMT Silence Therapeutics Shares Surge Ahead of Phase 2 SANRECO Trial Results - sekbernews.idsekbernews.id · Mon, 10 Aug 2026 11:06:04 GMT

Timeline

Mon, 10 Aug 2026 18:02:18 GMTSilence posts mid-stage polycythemia vera win, preps for Phase III - FirstWord Pharma

Mon, 10 Aug 2026 14:15:58 GMTSilence Therapeutics Says Blood Cancer Trial Delivers 'Best-Case Outcome' - Benzinga

Mon, 10 Aug 2026 14:00:27 GMTSilence Therapeutics Announces Positive Phase 2 SANRECO Trial Outcomes for Divesiran in Polycythemia Vera - Kalkine Media

Mon, 10 Aug 2026 12:48:16 GMTSilence Therapeutics Reports Second Quarter 2026 Financial and Business Results - BioSpace

Mon, 10 Aug 2026 11:52:25 GMTSilence Therapeutics Q2 EPS of $(0.09) beats $(0.15) estimate - scanx.trade

Mon, 10 Aug 2026 11:41:31 GMTSilence announces results from Phase 2 SANRECO trial met primary endpoint - TipRanks

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.

Connected entities

Phase9 live mentions Divesiran6 live mentions Polycythemia Vera4 live mentions SANRECO Trial4 live mentions Silence Therapeutics3 live mentions Silence2 live mentions Best2 live mentions Case Outcome2 live mentions Silence Therapeutics Announces2 live mentions Therapeutics Announces Positive2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Sanreco Trial Outcomes.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

8 distinct publisher/source names are currently connected to this entity page.